summary
Introduced
10/06/2020
10/06/2020
In Committee
10/06/2020
10/06/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
To amend title XIX of the Social Security Act to prohibit additional rebates under the Medicaid program for certain noninnovator multiple source drugs. This bill prohibits additional rebates for certain drugs under the Medicaid Drug Rebate Program. Specifically, the bill prohibits additional rebates with respect to noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1.
AI Summary
This bill prohibits additional rebates under the Medicaid program for certain generic drugs, specifically noninnovator multiple-source drugs (i.e., generics) for which the average manufacturer price is less than $1 per unit. The Medicaid Drug Rebate Program requires drug manufacturers to provide rebates to state Medicaid programs, and this bill prevents those additional rebates from being applied to certain low-cost generic drugs. The goal is to maintain access to affordable generic medicines for Medicaid beneficiaries.
Committee Categories
Business and Industry
Sponsors (7)
G. Butterfield (D)*,
Dan Bishop (R),
Tony Cárdenas (D),
Billy Long (R),
David McKinley (R),
Tom O'Halleran (D),
Darren Soto (D),
Last Action
Referred to the House Committee on Energy and Commerce. (on 10/06/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/8529/all-info |
| BillText | https://www.congress.gov/116/bills/hr8529/BILLS-116hr8529ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr8529/BILLS-116hr8529ih.pdf.pdf |
Loading...